Article
AstraZeneca's COVID vaccine suffers a setback in nasal spray trial
Rating:
0.0
Views:
48
Likes:
1
Library:
1
Attempts by Oxford University researchers and AstraZeneca Plc to create a nasal-spray version of their jointly developed COVID-19 shot suffered a setback on Tuesday as initial testing on humans did not yield the desired protection.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value